Journal of the Korea Academia-Industrial cooperation Society (한국산학기술학회논문지)

The Korea Academia-Industrial cooperation Society (한국산학기술학회)
권호 표지
DOI QR코드

DOI QR Code

Factors affecting Diabetic Eye disease and Kidney disease Screening in Diabetic Patients

당뇨병 환자의 당뇨성 안질환 및 신장질환 합병증 검사 수검 여부에 영향을 주는 요인

  • Received : 2019.12.19
  • Accepted : 2020.04.03
  • Published : 2020.04.29
Download PDF
⟨ Previous Next ⟩

Abstract

This study was undertaken to investigate factors that affect the assessment of complications in diabetic eye and kidney diseases. Data was obtained from the National Community Health Survey, 2017. The subjects included were 25,829 respondents who had been diagnosed with diabetes. Logistic regression analysis was applied to determine the factors affecting associated diabetic eye disease (fundus examination) and kidney disease (microalbuminuria examination) complications. The diabetic eye disease complication rate was 35.6%, and diabetic kidney disease complication rate was 39.8%. Complications arising due to diabetes were determined to be 35.6% for eye diseases and 39.8% for kidney related diseases. Ed. Notes: The original sentence is not very lucid. I have suggested an alternate edit. I leave it to the author's discretion to accept or reject the same. Please delete whichever sentence is not suitable. Walking activity (OR=1.03, OR=1.02), hemoglobin A1c (HbA1c) recognition (OR=2.33, OR=2.33), blood glucose level recognition (OR=1.61, OR=1.71), diabetes drug therapy (OR=2.67, OR=3.05), and diabetic management education (OR=1.45, OR=1.47) were more likely to be evaluated for eye and kidney disease complications. Our results indicate that to increase the rate of screening for diabetic complications, it is necessary to develop a diabetes management system that includes the type and timing of diabetic complications, as well as different promotional methods that recognize HbA1C and blood glucose levels. Ed. Notes: Do you mean 'screening' methods? Please revise appropriately, if required. In addition, it is essential to develop a guideline for the management of diabetes mellitus, and to incorporate a screening test for diabetic complications in the national screening system.

연구목적은 당뇨성 안질환 및 신장질환 합병증 검사 수검여부에 영향을 주는 요인을 알아보기 위함이다. 본 연구는 2017년 지역사회 건강조사 전국 자료를 이용하였으며, 연구대상은 의사에게 당뇨병을 진단받은 적이 있다고 응답한 사람 25,829명이다. 당뇨병 환자의 당뇨성 안질환 및 신장질환 합병증 검사 수검여부에 영향을 주는 요인을 알아보기 위해 로지스틱 회귀분석을 실시하였다. 연구결과는 당뇨병 환자 중 당뇨성 안질환 합병증 검사 수검율은 35.6%, 당뇨성 신장질환 합병증 검사 수검률은 39.8%이었다. 걷기실천을 할수록(OR=1.03, OR=1.02), 당화혈색소(OR=2.33, OR=2.33) 및 혈당수치(OR=1.61, OR=1.71)를 인지하는 사람과 현재 당뇨병 치료(OR=2.67, OR=3.05) 및 당뇨병 관리교육(OR=1.45, OR=1.47)을 받는 사람의 당뇨성 안질환 및 신장질환 합병증 검사를 받을 가능성이 많았다. 결론적으로 당뇨성 합병증 검사 수검율을 높이기 위해서는 당뇨병 환자를 대상으로 당뇨성 합병증 검사의 종류와 검사 시기가 포함된 당뇨병 관리 교육체계와 당화혈색소 및 혈당수치를 인지시킬 수 있는 다양한 홍보 방법 등이 개발되어야 할 것으로 생각된다. 그리고 당뇨병 관리를 위한 가이드라인 개발하고, 국가차원에서 국가검진제도에 당뇨성 합병증 검사 선별검사항목을 포함하는 등 시스템이 필요할 것으로 보인다.

Keywords

References

  1. S. Y. Kim, E. H. Nah, S. Cho. "Prevalence of Comorbidities among Patients with Diabetes", J Health Info Stat, Vol.43, No.3, pp.237-244, August 2018. DOI: https://doi.org/10.21032/jhis.2018.43.3.237
  2. World Health Organization. "Diabetes [Internet]". World Health Organization. WHO 2020. [cited 28 February 2018]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
  3. Statistics Korea, "Diabetic prevalence trend: sex, over 30 years old" [Internet]. Seoul. Statistics Korea 2019. [cited 2019 July 20]. Available from http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_11702_N102
  4. Health Insurance Review and Assessment Service/National Health Insurance Service, "2017 National Health Insurance statistical yearbook", [Internet]. Gangwon-do. Health Insurance Review and Assessment Service/National Health Insurance Service. 2018. [cited 2019 July 05], Available from: https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020045020000&brdScnBltNo=4&brdBltNo=2310&pageIndex=1#none
  5. K. N. D. Van Eijk, J. W. Blom, J. Gussekloo, B. C. P. Polak, Y. Groeneveld. "Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance", Diabetes research and clinical practice, Vol.96, No.1, pp.10-16, 2012. DOI: https://doi.org/10.1016/j.diabres.2011.11.003
  6. Y. L. Hsieh, F. H.Lee, C. L. Chen, M. F. Chang, P. H. Han. "Factors influencing intention to receive examination of diabetes complications", Asian Nursing Research, Vol.10, No.4, pp.289-294, 2016. DOI: https://doi.org/10.1016/j.anr.2016.10.004
  7. S. D. An, J. O. Yu. "Factors Influencing Fundus Examination in Patients with Diabetes", Journal of Korean Public Health Nursing, Vol.32, No.1, pp.44-55, 2018. DOI: https://doi.org/10.5932/JKPHN.2018.32.1.44
  8. Statistics Korea. "Annual Diabetes eye and Renal Disease Complication Test Rate(over 30 years old)", [Internet]. Seoul. Ministry of Health and Welfare/Korea Center for Disease control & Prevention. 2019. [cited 2019 July 20]. Available from: http://kosis.kr/statisticsList/statisticsListIndex.do?menuId=M_01_01&vwcd=MT_ZTITLE&parmTabId=M_01_01&statId=2008057&themaId=D#117_A01.3
  9. American Diabetes Association. "Strategies for Improving Care. Diabetes Care", Vol. 38, No.1, pp.S5-S7, 2015. DOI: https://doi.org/10.2337/dc15-S004
  10. American Diabetics Disease. "Complications", [Internet]. Arlington. American Diabetes Association. 2019. [cited 2019 July 20]. Available from: http://www.diabetes.org/living-with-diabetes/complications/
  11. J. L. Harding, M. E. Pavkov, D. Magliano, J. E. Shaw, E. W. Gregg. "Global trends in diabetes complications: a review of current evidence", Diabetologia, Vol.62, No.1, pp.3-16, 2019. DOI: https://doi.org/10.1007/s00125-018-4711-2
  12. E. Prokofyeva, E. Zrenner. "Epidemiology of major eye diseases leading to blindness in Europe: a literature review", Ophthalmic Res, Vol.47, No.4, pp.171-188, 2012. DOI: https://doi.org/10.1159/000329603
  13. M. N. Martin, W. U. Michael. "Diabetic retinopathy-ocular complications of diabetes mellitus", World journal of Diabetes, Vol.6, No.3, pp489-499, 2015. DOI: http://dx.doi.org/10.4239/wjd.v6.i3.489
  14. J. W. Yau,. L. Rogers, R. Kawasaki, E. L. Lamoureux, J. W. Kowalski, T. Bek. et al. "Global prevalence and major risk factors of diabetic retinopathy", Diabetes Care, Vol.35, No.3, pp.556-564, 2015. DOI: https://doi.org/10.2337/dc11-1909
  15. I. Kocur, S. Resnikoff. "Visual impairment and blindness in Europe and their prevention", British Journal of Ophthalmology, Vol.86, pp.716-722. 2002. DOI: http://dx.doi.org/10.1136/bjo.86.7.716
  16. E. Meda. Pavkov, L. Jessica. Harding, B. Chiu-Fang Chou, Jinan. Saaddine. "Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease", American Journal of Ophthalmology, Vol.198, pp.200-208, 2019. DOI: https://doi.org/10.1016/j.ajo.2018.10.019
  17. W. C. Lee, N. Y. Hong, J. B. Park, B. Y. Bae. "Improving Eye Examination Rate in Diabetic Patients in Bucheon", Monthly Community Health Report, pp.20-21. May 2018. DOI: https://chs.cdc.go.kr/chs/hd/hdMain.do
  18. P. Rossing, M. Marie Frimodt-Moller. "Clinical Features and Natural Course of Diabetic Nephropathy", Diabetic Nephropathy, pp.21-32, 2019.
  19. O. I. Ameh, I. G. Okpechi, C. Agyemang, A. P. Kengne. "Global, Regional, and Ethnic Differences in Diabetic Nephropathy", Diabetic Nephropathy, pp.33-44, 2019.
  20. A. M. Warren, S. T. Knudsen, M. E. Cooper. "Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies", Journal Expert Opinion on Therapeutic Targets, Vol.23, No.7, pp.579-591, 2019. DOI: https://doi.org/10.1080/14728222.2019.1624721
  21. Y. E. Son, S. Y. Ryu, J. Park, M. A. Han, H. M. Gu. "The Associated Factors with Utilization of Tests for Diabetes Complication and Hemoglobin A1c among Some Diabetes Patients", Health Policy and Management, Vol.26, No.3, pp.207-218, 2016. DOI: http://dx.doi.org/10.4332/KJHPA.2016.26.2.207
  22. Health Insurance Review & Assessment Service. "Guidelines for Changes in the Standards for Diabetes Adequacy Assessment", [Internet]. Seoul. Health Insurance Review & Assessment Service. 2019. [cited 2019 July 05]. Available from : http://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020002000100&brdScnBltNo=4&brdBltNo=7324
  23. S. H. Lee, H. L. Kim. "Comparision of Health Behaviors, Diabetes Mellitus(DM) Management and Health-related Quality of Life(HRQoL) between DM Groups with and without Diabetic Education Experience", Journal of agricultural medicine and community health, Vol.43, No.2, pp.:85-96, 2018. DOI: https://doi.org/10.5393/JAMCH.2018.43.2.085
  24. S. J. Park, H. J. Seo, D. Y. Lee, D. H. Nam. "Main Reasons for and Associated Factors of the First Fundus Examination in Diabetic Patients", J Korean Ophthalmol Soc, Vol.57, No.7, pp.1080-1086, 2016. DOI: http://dx.doi.org/10.3341/jkos.2016.57.7.1080
  25. E. Dervan, D. Lillis, L. Flynn, A. Staines, D. O'Shea. "Factors that influence the patient uptake of diabetic retinopathy screening", Irish Journal of Medical Science, Vol.177, No.4, pp.303-308, 2018. https://doi.org/10.1007/s11845-008-0192-5
  26. A. M. Kriska, M. A. Pereira, R. L. Hanson, M. P. De Courten, P. Z. Zimmet, K. G. M. Alberti. et al. "Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI", Diabetes care, Vol.24, No7, pp.1175-1180, 2001. DOI: https://doi.org/10.2337/diacare.24.7.1175
  27. American Diabetes Association. "Strategies for Improving Care", Diabetes Care, Vol.38, No.1, pp. S5-S7, January 2015. DOI: https://doi.org/10.2337/dc15-S004
  28. H. T. Lim, K. S. Cho. "Factors associated with screening for diabetic retinopathy in diabetic patients aged ${\geq}$ 40 years using the KNHANES IV", J Korean Ophthalmol Soc, Vol.53, No.4, pp.516-521, 2012. DOI: http://dx.doi.org/10.3341/jkos.2012.53.4.516
  29. S. Y. Lee, C. W. Kim, J. H. Kang, N. K. Seo. "Unmet healthcare needs depending on employment status", Health Policy, Vol.119, pp.899-906, 2015. DOI: http://dx.doi.org/10.1016/j.healthpol.2014.09.007